Thermo Fisher Scientific
| Thermo Fisher Scientific Inc.
|
|
|---|---|
 |
|
| legal form | Corporation |
| ISIN | US8835561023 |
| founding | 1902 as Fisher Scientific |
| Seat | Waltham , Massachusetts , USA |
| management | Marc N. Casper, President and CEO |
| Number of employees | approx. 70,000 (2019) |
| sales | $ 25.5 billion (2019) |
| Branch | Laboratory supplier, pharmaceuticals |
| Website | www.thermofisher.com |
| As of December 31, 2019 | |
Thermo Fisher Scientific Inc. ( NYSE : TMO), or Thermo Fisher for short , is an American technology company based in Waltham , Massachusetts . It describes itself as "the world's largest supplier of scientific applications."
Thermo Fisher has around 70,000 employees worldwide and achieved sales of US $ 25.5 billion in 2019.
Company history
Thermo Fisher Scientific was formed in November 2006 with the takeover of Fisher Scientific International Inc. by Thermo Electron Corp. and its subcontractor ThermoQuest . The Thermo Electron Corp. Which was founded in 1956, but previously numerous analysis Company had (such. B. Finnigan MAT , Fisons instruments (in part), Carlo Erba strumentazione , Nicolet Instrument Corporation ) acquired whose activities are now under the umbrella of Thermo Fisher Scientific been combined . Since May 17, 2011, the Dionex Corporation has also officially been part of the Thermo Fisher Scientific group of companies .
The biotech company Brahms was taken over at the end of 2009 . In May 2011, Thermo Fisher Scientific Inc. bought Phadia , a company that produces tests for allergies and autoimmune diseases, for € 2.47 billion .
In April 2013, after a bidding war with Hoffmann-La Roche , Thermo Fisher announced that it would take over Life Technologies Corp for $ 13.6 billion. This takeover was completed in February 2014.
In 2016 Thermo Fisher acquired FEI for $ 4.2 billion and in 2017 Patheon for $ 7.2 billion.
On March 3, 2020, it was announced that Thermo Fisher Scientific intended to acquire Qiagen . At least 75% of the shares should be bought at 39 €, approx. 23% above the market price at the time. The offer was supported by the Qiagen Management Board and Supervisory Board. The offer was later increased to € 43 and the acceptance threshold lowered to 66.66%. The takeover offer expired on August 10, 2020, by which time only 47.02% of the shares had been offered. Qiagen then had to pay Thermo Fisher a reimbursement of US $ 95 million.
Products
A main product of Thermo are coupling technologies of mass spectrometers with chromatography devices . Among other mass spectrometer with quadrupole ( DSQ , TSQ ), the ion trap technique ( ion trap ) and Orbitrap offered as well as multiple mass spectrometer mass spectrometer both in the form easier.
Analysis devices can be coupled with inductively coupled plasma (ICP) in the form of gas chromatographs (GC), liquid chromatographs (HPLC), capillary electrophoresis (CE) and mass spectrometry . Additional detectors are also available for the chromatography devices.
Further products include the following analysis techniques:
- AAS ( atomic absorption spectrometry )
- FT-IR spectroscopy
- Electron microscope ie
- Infrared microscopy
- Laboratory extruder, laboratory mixer
- Near infrared analyzers
- OES ( atomic emission spectrometry )
- Raman Spectroscopy
- Rheometer, viscometer
- X-ray photoelectron spectroscopy
- UV-Vis spectrophotometer
- XRF / XRD (energy and wavelength dispersive X-ray fluorescence analysis )
Thermo Fisher Scientific also develops corresponding chromatography evaluation software (e.g. Xcalibur and Dionex Chromeleon ) and laboratory information and management systems (LIMS).
The company is also a leading global supplier of laboratory consumables and chemicals.
Web links
Individual evidence
- ↑ a b company profile , accessed April 28, 2020
- ↑ a b Annual Report 2019 , accessed on April 28, 2020
- ↑ Thermo Fisher Scientific: News Release ( English ) ir.thermofisher.com. Archived from the original on July 22, 2012. Retrieved October 13, 2008.
- ↑ Thermo Scientific: Former brand names . www.thermo.com. Retrieved July 17, 2011.
- ↑ Thermo Fisher Scientific Completes Tender Offer for Dionex Corporation ( English ) www.dionex.com. Archived from the original on February 26, 2012. Retrieved July 17, 2011.
- ↑ Thermo Fisher Rises to Record After $ 3.5 Billion Phadia Buy - Bloomberg .
- ^ Z. Brennan (March 2013). Price of Life Tech Steady at $ 11B as Roche Joins Bidding War .
- ↑ Bill Berkrot, Susan Kelly: Thermo Fisher to buy Life Tech for $ 13.6 trillion , Reuters. April 15, 2013.
- ^ Thermo Fisher Scientific Completes Acquisition of Life Technologies Corporation .
- ↑ Billion merger with laboratory equipment suppliers: Thermo Fisher buys microscope specialist FEI , Handelsblatt , May 27, 2016.
- ↑ http://www.genengnews.com/gen-news-highlights/thermo-fisher-scientific-to-acquire-patheon-for-72b/81254347
- ↑ QIAGEN shares shoot up: Thermo Fisher presents takeover bid for QIAGEN. In: finanzen.net. March 3, 2020, accessed March 4, 2020 .
- ↑ Thermo Fisher increases offer for Qiagen - investor demands more. In: handelsblatt.com. July 17, 2020, accessed August 14, 2020 .
- ↑ Solinger Tageblatt of August 14, 2020, page 12
- ↑ Largest takeover in the German biotech industry has failed. In: handelsblatt.com. August 13, 2020, accessed on August 14, 2020 .